LTS Lohmann Therapie- Systeme AG, Germany
| Държава: | ----- |
| Кратка информация: | LTS – Worldwide Technology Leader in our Business Divisions LTS is the global leader in the development and manufacture of transdermal systems and oral thin films. The products developed by LTS comprise a multitude of innovations, including the world-wide first nicotine patch as well as the only patch against Parkinson's and Restless-Legs-Syndrome. This is also the first medication in the world which was developed as a patch formulation right from the very beginning. The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS Corp has already produced more than a billion strips in the first three years after market launching. More than 5,000 patents reinforce our top position in development of this technologies. Since the end of the 1990s, LTS is also the principal shareholder of "CRS Clinical Research Services", which conducts phases I to IV clinical trials. LTS offers the entire service spectrum, starting with development and continuing to clinical trials and production up to final packaging. LTS Competencies When it comes to developing new successful products from active ingredients, our international customers in the pharmaceutical industry can rely on a broad range of competencies: LTS Competence in Research and Development As innovation leader with over 170 employees in research and development, we supply new dosage forms when existing galenic concepts cannot be employed or cannot act optimally or create compliance problems. LTS Competence in Clinical Trials We conduct phase I to IV clinical trials with CRS Clinical Research Services Andernach GmbH as well as its subsidiaries belonging to the LTS group. Comprehensive answers to almost all topics of clinical pharmacology can be found within a short time. LTS Competence in Technological Diversity Starting with the requirements and targets of our customer, we create a solution for each medication presented. And that means we develop a new, customized technology. This makes us an innovative and ideal partner of the pharmaceutical industry. LTS Competence in Production and Packaging We can also produce what we develop. And if required, we will invent a completely new production procedure especially for your product. We offer the entire scope of production, from the laboratory scale up to global market capacities. Our full service comprises complex active ingredient substances, elaborate coatings and laminations, stamping, and attractive, user-friendly solutions for primary and secondary packaging. From a vision to leading partner of the pharmaceutical industry It began with the vision of the transdermal therapeutic system and developed into a success story sustained to this day. In 1984 the LTS LOHMANN Therapie-System GmbH & Co. KG was founded in Neuwied; soon afterwards the first successful products were already being marketed, including a nitroglycerine patch for the preventive treatment of angina pectoris and the world-wide first nicotine patch. LTS was founded as a subsidiary of the Lohmann Group. The former parent company Lohmann was founded in 1851 and is active in different business sectors – medical products, adhesive tape systems, and spunbonded fabrics. In 1999 the company was converted into a stock company. In the more than 26 years of the company's existence, LTS has expanded into one of the world-wide principal suppliers of transdermal and oral systems for the international pharmaceutical industry. |
| Сайт: | http://www.ltslohmann.com/ |
